🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/03/2002 59,88 60,09 58,98 58,98 -1,90% 1,85% 5.888.398
04/03/2002 59,87 60,37 59,35 60,12 +0,05% 1,71% 5.961.129
01/03/2002 58,55 60,10 58,50 60,10 +2,69% 2,72% 5.145.890
28/02/2002 57,87 58,91 57,87 58,52 +0,74% 1,80% 4.860.624
27/02/2002 58,32 59,62 57,60 58,09 +0,38% 3,47% 7.413.133
26/02/2002 58,04 58,67 57,50 57,87 -0,31% 2,02% 5.393.532
25/02/2002 58,34 58,59 57,62 58,05 -1,07% 1,65% 6.214.221
22/02/2002 57,82 59,09 57,76 58,68 +0,80% 2,31% 6.151.550
21/02/2002 58,45 59,26 58,19 58,22 -0,41% 1,83% 7.516.675
20/02/2002 56,55 58,66 56,36 58,45 +3,39% 4,08% 7.617.807
19/02/2002 56,42 57,01 56,20 56,54 -0,94% 1,44% 4.251.946
15/02/2002 56,96 57,21 56,56 57,07 +0,20% 1,16% 7.360.104
14/02/2002 57,29 57,40 56,44 56,96 -1,47% 1,67% 6.589.719
13/02/2002 57,54 57,91 57,01 57,81 +0,60% 1,56% 5.761.275
12/02/2002 56,60 57,78 56,50 57,46 +1,30% 2,26% 6.067.815
11/02/2002 56,45 56,85 55,96 56,73 +0,51% 1,57% 4.280.346
08/02/2002 55,40 57,24 55,06 56,44 +1,41% 3,94% 5.242.725
07/02/2002 55,84 56,38 55,40 55,66 -0,49% 1,76% 4.635.409
06/02/2002 56,30 56,58 55,73 55,94 -1,31% 1,53% 4.238.007
05/02/2002 55,34 56,89 55,27 56,68 +1,64% 2,93% 4.716.419
04/02/2002 56,71 56,72 55,46 55,76 -1,67% 2,22% 4.371.627
01/02/2002 56,32 56,87 56,23 56,71 +0,42% 1,14% 4.906.422
31/01/2002 55,87 56,56 55,59 56,47 +0,58% 1,74% 6.833.274
30/01/2002 55,32 56,77 55,08 56,15 +2,29% 3,07% 10.328.564
29/01/2002 55,58 56,15 54,48 54,89 +0,91% 3,02% 12.117.919
28/01/2002 54,67 54,68 54,11 54,39 +0,07% 1,03% 5.198.709
25/01/2002 54,56 54,68 54,20 54,35 -1,15% 0,87% 6.826.043
24/01/2002 55,35 55,52 54,69 54,98 -1,08% 1,50% 7.385.151
23/01/2002 56,75 57,14 55,58 55,58 -1,75% 2,74% 7.475.908
22/01/2002 55,76 56,77 55,76 56,57 +2,22% 1,80% 5.512.480